10-1 Report: After-Action ReviewBusiness School, Southern New Hampshire UniversityMBA-699-Q4858 Strategic Opportunity Mgmt 24TW4 09:03:43 GMT -05:00AAR OverviewThe board of directors has agreed to the acquisition of our life science firm, a decisionthat we understand was not without its challenges, particularly with the primary buyer. However, the alternate buyer, Johnson and Johnson, has successfully closed the deal. As we navigate through the first three months of the acquisition, we acknowledge that some aspects are not unfolding as anticipated. This is an opportune time for an AAR analysis, which can guide us in rectifying our future actions and leveraging past experiences for learning.Expected OutcomeThe common expectations were to increase financial performance, successfully integrate as one, and increase employee retention while transitioning from the largest life science firm in the Midwest to the largest life science firm post-acquisition. Outlining a clear vision for thefuture integration of the firms has been the focal point during the acquisition, and surveying employees to gauge their stress levels during the acquisition to stay on top of attrition.Actual outcomeThe most recent attrition report reveals that in 3 months, 5% of the original workforce found the acquisition to be stressful and decided to leave the